Development and validation of a risk scoring system to identify patients with lupus nephritis in electronic health record data

被引:1
|
作者
Izadi, Zara [1 ]
Gianfrancesco, Milena [1 ]
Anastasiou, Christine [1 ]
Schmajuk, Gabriela [1 ,2 ]
Yazdany, Jinoos [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] San Francisco VA Med Ctr, San Francisco, CA USA
来源
LUPUS SCIENCE & MEDICINE | 2024年 / 11卷 / 01期
关键词
Lupus Nephritis; Lupus Erythematosus; Systemic; Epidemiology; Antibodies; Antirheumatic Agents; ERYTHEMATOSUS; IDENTIFICATION; CLASSIFICATION;
D O I
10.1136/lupus-2024-001170
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Accurate identification of lupus nephritis (LN) cases is essential for patient management, research and public health initiatives. However, LN diagnosis codes in electronic health records (EHRs) are underused, hindering efficient identification. We investigated the current performance of International Classification of Diseases (ICD) codes, 9th and 10th editions (ICD9/10), for identifying prevalent LN, and developed scoring systems to increase identification of LN that are adaptable to settings with and without LN ICD codes.Methods Training and test sets derived from EHR data from a large health system. An external set comprised data from the EHR of a second large health system. Adults with ICD9/10 codes for SLE were included. LN cases were ascertained through manual chart reviews conducted by rheumatologists. Two definitions of LN were used: strict (definite LN) and inclusive (definite, potential or diagnostic uncertainty). Gradient boosting models including structured EHR fields were used for predictor selection. Two logistic regression-based scoring systems were developed ('LN-Code' included LN ICD codes and 'LN-No Code' did not), calibrated and validated using standard performance metrics.Results A total of 4152 patients from University of California San Francisco Medical Center and 370 patients from Zuckerberg San Francisco General Hospital and Trauma Center met the eligibility criteria. Mean age was 50 years, 87% were female. LN diagnosis codes demonstrated low sensitivity (43-73%) but high specificity (92-97%). LN-Code achieved an area under the curve (AUC) of 0.93 and a sensitivity of 0.88 for identifying LN using the inclusive definition. LN-No Code reached an AUC of 0.91 and a sensitivity of 0.95 (0.97 for the strict definition). Both scoring systems had good external validity, calibration and performance across racial and ethnic groups.Conclusions This study quantified the underutilisation of LN diagnosis codes in EHRs and introduced two adaptable scoring systems to enhance LN identification. Further validation in diverse healthcare settings is essential to ensure their broader applicability.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Development and validation of automated electronic health record data reuse for a multidisciplinary quality dashboard
    Ebbers, Tom
    Takes, Robert P.
    Honings, Jimmie
    Smeele, Ludi E.
    Kool, Rudolf B.
    van den Broek, Guido B.
    DIGITAL HEALTH, 2023, 9
  • [32] Development and validation of lupus nephritis case definitions using United States veterans affairs electronic health records
    Li, Tingting
    Lee, Iris
    Jayakumar, Divya
    Huang, Xinliang
    Xie, Yan
    Eisen, Seth
    Ranganathan, Prabha
    LUPUS, 2021, 30 (03) : 518 - 526
  • [33] Development and validation of an electronic frailty index using routine primary care electronic health record data
    Clegg, Andrew
    Bates, Chris
    Young, John
    Ryan, Ronan
    Nichols, Linda
    Teale, Elizabeth Ann
    Mohammed, Mohammed A.
    Parry, John
    Marshall, Tom
    AGE AND AGEING, 2016, 45 (03) : 353 - 360
  • [34] Development and validation of machine learning models to identify high-risk surgical patients using automatically curated electronic health record data (Pythia): A retrospective, single-site study
    Corey, Kristin M.
    Kashyap, Sehj
    Lorenzi, Elizabeth
    Lagoo-Deenadayalan, Sandhya A.
    Heller, Katherine
    Whalen, Krista
    Balu, Suresh
    Heflin, Mitchell T.
    McDonald, Shelley R.
    Swaminathan, Madhav
    Sendak, Mark
    PLOS MEDICINE, 2018, 15 (11)
  • [35] Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality
    Tumbarello, Mario
    Trecarichi, Enrico Maria
    Caira, Morena
    Candoni, Anna
    Pastore, Domenico
    Cattaneo, Chiara
    Fanci, Rosa
    Nosari, Annamaria
    Spadea, Antonio
    Busca, Alessandro
    Vianelli, Nicola
    Spanu, Teresa
    Pagano, Livio
    PLOS ONE, 2012, 7 (12):
  • [36] Development and validation of a dynamic inpatient risk prediction model for clinically significant hypokalemia using electronic health record data
    Li, Yan
    Staley, Benjamin
    Henriksen, Carl
    Xu, Dandan
    Lipori, Gloria
    Winterstein, Almut G.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (05) : 301 - 311
  • [37] Validation of diagnosis codes to identify side of colon in an electronic health record registry
    Patricia Luhn
    Deborah Kuk
    Gillis Carrigan
    Nathan Nussbaum
    Rachael Sorg
    Rebecca Rohrer
    Melisa G. Tucker
    Brandon Arnieri
    Michael D. Taylor
    Neal J. Meropol
    BMC Medical Research Methodology, 19
  • [38] Validation of diagnosis codes to identify side of colon in an electronic health record registry
    Luhn, Patricia
    Kuk, Deborah
    Carrigan, Gillis
    Nussbaum, Nathan
    Sorg, Rachael
    Rohrer, Rebecca
    Tucker, Melisa G.
    Arnieri, Brandon
    Taylor, Michael D.
    Meropol, Neal J.
    BMC MEDICAL RESEARCH METHODOLOGY, 2019, 19 (01)
  • [39] Using ICD-10-CM Codes to Identify Patients with Systemic Lupus Erythematosus in the Electronic Health Record
    Barnado, April
    Carroll, Robert
    Denny, Joshua C.
    Crofford, Leslie
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [40] Development and validation a simple scoring system to identify malignant pericardial effusion
    Jin, Xiaxia
    Hu, Lingling
    Fang, Meidan
    Zheng, Qiaofei
    Yuan, Yuan
    Lu, Guoguang
    Li, Tao
    FRONTIERS IN ONCOLOGY, 2022, 12